These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6327489)

  • 1. Lack of glucagon receptors in Morris hepatoma 7800.
    Mourelle M; Rojkind M
    Hepatology; 1984; 4(3):515-9. PubMed ID: 6327489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane receptor function and the loss of glucagon-stimulated adenylate cyclase activity in hepatomas.
    Mirel RD; Morris HP; DiAugustine RP
    Endocrinology; 1978 Apr; 102(4):1237-46. PubMed ID: 217618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-ethylmaleimide uncouples the glucagon receptor from the regulatory component of adenylyl cyclase.
    Lipson KE; Kolhatkar AA; Dorato A; Donner DB
    Biochemistry; 1986 Sep; 25(19):5678-85. PubMed ID: 3022802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some enzyme and hormonal attributes of hepatoma cell membranes.
    Mourelle M; Morris HP; Rubalcava B
    Toxicology; 1980; 15(3):173-80. PubMed ID: 6258269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of glucagon receptors in Golgi fractions of rat liver: evidence for receptors that are uncoupled from adenylyl cyclase.
    Lipson KE; Kolhatkar AA; Cherksey BD; Donner DB
    Biochemistry; 1986 May; 25(9):2612-20. PubMed ID: 3013309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1004-12. PubMed ID: 6323531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
    Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
    J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the adenylate cyclase system in transplantable hepatomas.
    Criss WE; Morris HP
    Cancer Res; 1976 May; 36(5):1740-3. PubMed ID: 178431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of glucagon responsiveness in spontaneously transformed rat hepatocytes (RL-PR-C) by fusion with normal progenitor cells and rat liver plasma membranes.
    Reilly TM; Blecher M
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):182-6. PubMed ID: 6264432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2+ and enhancing its extent of activation by guanine nucleotides.
    Iyengar R; Birnbaumer L
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5179-83. PubMed ID: 6291028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of glucagon receptor from liver membranes to a foreign adenylate cyclase by a membrane fusion procedure.
    Schramm M
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1174-8. PubMed ID: 220608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the epinephrine-mediated activation of adenylate cyclase in plasma membranes from liver and ascites hepatomas of rats.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1976 Dec; 455(2):297-314. PubMed ID: 187240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.
    Livingston JN; Einarsson K; Backman L; Ewerth S; Arner P
    J Clin Invest; 1985 Feb; 75(2):397-403. PubMed ID: 2982913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase.
    Houslay MD; Dipple I; Elliott KR
    Biochem J; 1980 Mar; 186(3):649-58. PubMed ID: 6249258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal changes and adenylate cyclase system in rat bearing 7800 Morris hepatoma.
    Mourelle M
    J Appl Toxicol; 1983 Feb; 3(1):9-13. PubMed ID: 6348140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hepatic glucagon receptor: a comparative study of the regulatory and structural properties.
    Padrell E; Herberg JT; Monsatirsky B; Floyd G; Premont RT; Iyengar R
    Endocrinology; 1987 Jun; 120(6):2316-25. PubMed ID: 3032585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
    McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
    Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin receptor-adenylate cyclase system in plasma membranes of rat liver and ascites hepatomas, and the effect of GTP upon it.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1977 Feb; 465(1):54-67. PubMed ID: 189813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the mouse major histocompatibility complex, H-2, on liver adenylate cyclase activity and on glucagon binding to liver cell membranes.
    Lafuse W; Edidin M
    Biochemistry; 1980 Jan; 19(1):49-54. PubMed ID: 6243475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal matrix recognition by Morris hepatomas correlates with low glucagon binding capacity.
    Mourelle M; Cordero-Hernández J; Ponce-Noyola P; Rojkind M
    Hepatology; 1983; 3(3):303-7. PubMed ID: 6840676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.